Team S on Newnex: Predicta Biosciences has secured $5.2M in a Seed…

Predicta Biosciences has secured $5.2M in a Seed funding round to…

Team S · 2024-07-18T12:36:18.000Z

Predicta Biosciences has secured $5.2M in a Seed funding round to revolutionize the diagnosis, treatment, and monitoring of blood cancers. Founded by Dr. Sarah Johnson and Dr. Emily Carter, the company is based in San Francisco, CA. This round was led by BioHealth Ventures with participation from MedTech Innovators and other notable investors. #HealthcareInnovation #Biotech #BloodCancer #FundingNews https://www.businesswire.com/news/home/20240716981153/en/Predicta-Biosciences-Secures-5.2M-to-Transform-the-Diagnosis-Treatment-and-Monitoring-of-Blood

Member Login Get Access

Team S on Newnex: Predicta Biosciences has secured $5.2M in a Seed…